Current guidelines do not recommend switching between different levothyroxine products due to concerns of potential changes in TSH levels. However, getting the same levothyroxine product every time may be difficult for patients due to financial or stocking constraints. Join your host, Geoff Wall, and guest, Dr. Jamie Pitlick to discuss a recent study that examined the consequences of switching between levothyroxine products. 

The GameChanger

Based on a recent study, switching between different levothyroxine products may not significantly or clinically impact TSH levels in patients. 

Show Segments

00:00 – Introduction
01:12 – Generic Substitution of Generic Levothyroxine Products 
03:17 – Bioequivalence of Levothyroxine Products 
15:42 – The GameChanger 
24:47 – Closing Remarks 

Host

Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest

Jamie Pitlick, PharmD, BCPS, PC-ADM
Associate Professor of Pharmacy Practice, Drake University
Diabetes/Endocrinology Care, Iowa Diabetes

References and Resources

Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US Adults

Redeem your CPE or CME credit here!

• Pharmacist members
• CME

Need a membership?

• Join for CPE Credit 
• Join for CME Credit

 Continuing Education Information:

Learning Objectives:

1. Describe the outcomes of the study evaluating the impact of switching levothyroxine generic manufacturers

2. Discuss with patients the results of the study and clinical implications

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-144-H01-P
Initial release date: 04/11/22
Expiration date: 04/11/2023
Additional CPE & CME details can be found here!

Follow CEimpact on Social Media:
LinkedIn
Instagram